Retraction: Exploring the therapeutic potential of IL-17A inhibition in myasthenia gravis: a retrospective study on secukinumab
{{output}}
[This retracts the article DOI: 10.1136/bmjno-2025-001249.]. Copyright © Author(s) (or their employer(s)) 2026. Re-use permitted under CC BY-NC. No commercial re-use. See r... ...
